The US Food and Drug Administration has approved Bristol-Myers Squibb's immunotherapy Opdivo as a treatment for the most common form of bladder cancer. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/bladder_cancer_nod_for_bms_opdivo_1185762NHS use of Eli Lilly's Alimta to treat patients with lung cancer has been endorsed in final draft guidance from the National Institute for Health and Care Excellence. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/lillys_alimta_wins_nice_support_1077307Janssen has submitted a marketing application to the European Medicines Agency (EMA) seeking approval of investigational nasal spray esketamine for the treatment of major depressive disorder. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/janssen_files_nasal_spray_for_depression_1255351Germany’s Merck is considering the future of its consumer health segment, including a potential full or partial sale of the business as well as new strategic partnerships. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/merck_considers_future_of_consumer_health_unit_1204315UK-based Martindale Pharma has announced regulatory clearance of an oral formulation of its epilepsy therapy clobazam in Europe. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/martindales_oral_epilepsy_drug_bags_eu_nods_1174519Pfizer’s biosimilar of Amgen’s epoetin alfa (Epogen/Procrit) has won backing in the US for approval across all proposed indications. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/pfizers_epogenprocrit_biosimilar_wins_us_backing_1194418Ferring's Rekovelle has been approved by European regulators for controlled ovarian stimulation in women undergoing assisted reproductive technologies. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/eu_nod_for_ferrings_rekovelle_1181697US regulators recently approved AstraZeneca’ gout therapy Zurampic, offering patients a new approach to treating the condition. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/az_gout_therapy_wins_us_approval_1020699AstraZeneca is divesting certain rights to its nasal inflammation spray Rhincort Aqua to Johnson & Johnson group Cilag GmbH International. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/az_sells_nasal_spray_rights_to_j_and_j_1158697The Association of the British Pharmaceutical Industry (ABPI) is linking arms with the Academic Health Science Network in a five-year partnership that strives to accelerate uptake of transformative biomedical innovations by the NHS - News -
by Selina McKee
www.pharmatimes.com/news/abpi_enters_five-year_partnership_with_ahsn_1252987
